Add to ORKGThe Author(s) 2013. This article is published with open access at Springerlink.com Background The burden of invasive meningococcal dis-ease is substantial in older adults in whom the case fatality rate is high. Travelers to regions with high rates of meningococcal disease, such as Hajj pilgrims, are at increased risk of meningococcal infection, and disease transmission from travelers to their close contacts has been documented. In younger individuals, meningococcal con-jugate vaccines offer advantages over polysaccharide vac-cines in terms of duration of protection and boostability, and induction of herd immune effects through reductions in nasopharyngeal carriage of meningococci. To date, few data are available evaluating meningococcal con...
SummaryBackgroundThis phase 3, multi-center, open-label study evaluated the immunogenicity and safet...
Background: An important development in the field of adult pneumococcal vaccination since the last C...
BACKGROUND: Randomised trials carried out over two decades ago showed that the polysaccharide vaccin...
Introduction: Vaccine responses are often reduced in the elderly, leaving part of the elderly popula...
Meningococcal conjugate vaccines are today successfully deployed in universal programs for children ...
In January 2011, the Food and Drug Administration lowered the approval age range for use of MenACWY-...
Background: Pneumococcal polysaccharide vaccine (PPV) is recommended for all adults 65 years of age ...
Introduction: Vaccine responses are often reduced in the elderly, leaving part of the elderly popula...
(See the editorial commentary by O’Brien, on pages 1326–8.) Background. Infections with pneumococci ...
Immunogenicity and safety of ACWY-TT compared with licensed ACWY polysaccharide vaccine (MenPS) in h...
International audienceMenB-FHbp (bivalent rLP2086; Trumenba®) is a recombinant protein-based vaccine...
Meningococcal disease, including meningitis and sepsis, usually follows an invasive infection by Nei...
Neisseria meningitidis is often asymptomatically carried in the nasopharynx but may cause invasive m...
Introduction: Successful vaccination of elderly persons is often hampered by immunological ageing, l...
Contains fulltext : 88187.pdf (publisher's version ) (Open Access)BACKGROUND: In 2...
SummaryBackgroundThis phase 3, multi-center, open-label study evaluated the immunogenicity and safet...
Background: An important development in the field of adult pneumococcal vaccination since the last C...
BACKGROUND: Randomised trials carried out over two decades ago showed that the polysaccharide vaccin...
Introduction: Vaccine responses are often reduced in the elderly, leaving part of the elderly popula...
Meningococcal conjugate vaccines are today successfully deployed in universal programs for children ...
In January 2011, the Food and Drug Administration lowered the approval age range for use of MenACWY-...
Background: Pneumococcal polysaccharide vaccine (PPV) is recommended for all adults 65 years of age ...
Introduction: Vaccine responses are often reduced in the elderly, leaving part of the elderly popula...
(See the editorial commentary by O’Brien, on pages 1326–8.) Background. Infections with pneumococci ...
Immunogenicity and safety of ACWY-TT compared with licensed ACWY polysaccharide vaccine (MenPS) in h...
International audienceMenB-FHbp (bivalent rLP2086; Trumenba®) is a recombinant protein-based vaccine...
Meningococcal disease, including meningitis and sepsis, usually follows an invasive infection by Nei...
Neisseria meningitidis is often asymptomatically carried in the nasopharynx but may cause invasive m...
Introduction: Successful vaccination of elderly persons is often hampered by immunological ageing, l...
Contains fulltext : 88187.pdf (publisher's version ) (Open Access)BACKGROUND: In 2...
SummaryBackgroundThis phase 3, multi-center, open-label study evaluated the immunogenicity and safet...
Background: An important development in the field of adult pneumococcal vaccination since the last C...
BACKGROUND: Randomised trials carried out over two decades ago showed that the polysaccharide vaccin...